We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+21.91%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$555M
AUM Growth
+$116M
Cap. Flow
+$80.5M
Cap. Flow %
14.51%
Top 10 Hldgs %
36.98%
Holding
283
New
99
Increased
41
Reduced
35
Closed
45

Sector Composition

Rank Sector Weight
1 Financials 21.62%
2 Healthcare 11.3%
3 Technology 7.48%
4 Industrials 6.89%
5 Communication Services 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INAQU
151
DELISTED
INSU Acquisition Corp. II Unit
INAQU
$270K 0.05%
+26,100
New +$274K
TV icon
152
Televisa
TV
$1.48B
$269K 0.05%
43,500
+8,000
+23% +$48.8K
CCI icon
153
Crown Castle
CCI
$31.6B
$266K 0.05%
+1,600
New +$264K
C icon
154
Citigroup
C
$231B
$259K 0.05%
6,000
-1,000
-14% -$49.8K
CI icon
155
Cigna
CI
$72.4B
$254K 0.05%
1,500
+200
+15% +$35.2K
DISH
156
DELISTED
DISH Network Corp.
DISH
$253K 0.05%
8,700
-300
-3% -$9.9K
PIC.WS
157
DELISTED
Pivotal Investment Corporation II Redeemable Warrants, each whole warrant exercisable for shares of
PIC.WS
$252K 0.05%
68,164
+13,232
+24% +$18.9K
STR
158
DELISTED
Sitio Royalties
STR
$251K 0.05%
25,679
DIS icon
159
Walt Disney
DIS
$178B
$248K 0.04%
2,000
-400
-17% -$50K
RESI
160
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$248K 0.04%
28,350
-41,762
-60% -$379K
CNH
161
CNH Industrial
CNH
$16.9B
$244K 0.04%
35,906
+1,149
+3% +$7.62K
CORT icon
162
Corcept Therapeutics
CORT
$12.2B
$233K 0.04%
13,400
-1,200
-8% -$19.1K
CLOVW
163
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$232K 0.04%
+60,000
New +$188K
ABBV icon
164
AbbVie
ABBV
$441B
$226K 0.04%
2,577
BDX icon
165
Becton Dickinson
BDX
$49B
$221K 0.04%
974
MRK icon
166
Merck
MRK
$328B
$216K 0.04%
+2,725
New +$213K
CCIV.U
167
DELISTED
Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth
CCIV.U
$210K 0.04%
+21,000
New +$210K
PRGO icon
168
Perrigo
PRGO
$1.7B
$207K 0.04%
4,500
BIO icon
169
Bio-Rad Laboratories Class A
BIO
$9.46B
$206K 0.04%
400
-100
-20% -$50.6K
CVS icon
170
CVS Health
CVS
$120B
$204K 0.04%
3,500
ELV icon
171
Elevance Health
ELV
$85.4B
$201K 0.04%
+750
New +$202K
BC icon
172
Brunswick
BC
$5.11B
$200K 0.04%
3,400
-1,000
-23% -$63.8K
ASTSW
173
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$200K 0.04%
+165,232
New +$165K
CCAC.WS
174
DELISTED
CITIC Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary sh
CCAC.WS
$200K 0.04%
+159,850
New +$133K
SDS icon
175
ProShares UltraShort S&P500
SDS
$370M
$199K 0.04%
500

Similar funds

Gabelli & Co Investment Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Gabelli & Co Investment Advisers held 283 positions worth $555M, up 26% from $439M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gabelli & Co Investment Advisers deployed $80.5M of net new capital in Q3 2020, opening 99 new positions and adding to 41 existing holdings. Its largest new stake was Momenta Pharmaceuticals, Inc.: 432,325 shares worth $22.7M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Tiffany & Co., an estimated $2.26M trimmed.

  • Gabelli & Co Investment Advisers's largest Q3 2020 buy was Momenta Pharmaceuticals, Inc.: 432,325 shares worth $22.7M.
  • Gabelli & Co Investment Advisers added most to Willis Towers Watson in Q3 2020, an estimated $19.1M increase.
  • Gabelli & Co Investment Advisers's biggest Q3 2020 reduction was Tiffany & Co., cutting an estimated $2.26M.
  • Gabelli & Co Investment Advisers fully exited El Paso Electric Company in Q3 2020, selling an estimated $28.5M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 37% of its $555M portfolio in Q3 2020.
  • Gabelli & Co Investment Advisers opened 99 new positions and closed 45 in Q3 2020.
  • Gabelli & Co Investment Advisers's portfolio value rose 26% quarter-over-quarter to $555M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2020, filed 6 Nov 2020.